Mechanism Deep Dive · Cardiopulmonary-Axis Diseases

How the nasal spray platform delivers along the cardiopulmonary axis to distant lesions

This category currently centers on myocardial infarction repair. Its significance is extending the nasal spray from a local mucosal product into a systemic delivery platform that crosses the alveolar barrier, enters circulation, and then homes to injured myocardium.

Caveolae Transcytosis

Key entry route for crossing type-I alveolar epithelium

SDF-1 / CXCR4

Homing / magnetic-attraction logic toward ischemic myocardium

miR-21

Core cargo for reducing hypoxic cardiomyocyte apoptosis

Erk1/2 + Bcl-2

Key anti-apoptotic pathway sustaining the repair window

Three-Step Mechanism

Delivery and action chain for myocardial infarction repair

These three steps follow the core logic you provided: cross the barrier first, home precisely second, then stabilize cell fate in the ischemic zone using functional cargo.

Barrier Crossing

Myocardial Infarction Repair

Entering circulation through caveolae-mediated transcytosis across type-I alveolar epithelium

After nasal administration, exosomes are not treated as molecules confined to the upper airway. They are designed to achieve epithelial transfer at the alveolar level. Through caveolae-mediated transcytosis, they can bypass part of the local degradation barrier and enter circulation, creating the prerequisite for delivery to distal cardiac tissue.

Alveolar uptakeCaveolae transcytosisBypass degradationEnter circulation

Precise Homing

Myocardial Infarction Repair

Using SDF-1 / CXCR4 signaling to home toward injured myocardium

Ischemic myocardium releases homing cues such as SDF-1, creating an attraction field for reparative delivery vehicles. Exosome surfaces can exploit CXCR4 responsiveness to this signal so that enrichment occurs preferentially in injured cardiac tissue rather than dispersing evenly throughout the body, improving lesion-level effective concentration per dose.

SDF-1 releaseCXCR4 targetingLesion enrichmentTargeted delivery

Anti-apoptotic Cargo

Myocardial Infarction Repair

Delivering miR-21 to activate Erk1/2 and Bcl-2 for cardiomyocyte fate stabilization

Once delivered to the injury zone, miR-21 functions as a core cargo that helps activate Erk1/2 signaling and upregulate Bcl-2, lowering the probability that hypoxic cardiomyocytes continue toward apoptosis. It is not framed as directly creating new myocardium, but as preserving salvageable cells first and securing time plus microenvironmental stability for subsequent repair.

miR-21Erk1/2 activationBcl-2 upLower apoptosis

Category Summary

Core value of the cardiopulmonary-axis page

The focus of this category page is not to enumerate many cardiac disease names, but to make the logic of distal-organ targeting through a nasal spray platform fully legible.

The core mechanism across the cardiopulmonary-axis category is extending synthetic biology exosomes from the nasal entry point through alveolar barrier crossing, systemic transport, and directed homing to ischemic myocardium — demonstrating an engineering capability for local administration with distal action. Through combined design of surface homing cues and internal miRNA cargo, the platform aims to reduce apoptosis during the key post-infarction window, stabilize the injury-site microenvironment, and preserve a stronger tissue foundation for downstream repair.

Back to Nasal Spray Research

Continue

Explore respiratory or CNS disease mechanisms

Across systems, the platform differs mainly in barrier-crossing route, homing behavior, and cargo configuration, while the underlying engineered signaling modules remain consistent.

Respiratory Diseases CNS Diseases